Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mair

Showing results (101-110 of 211) with videos related to

Pageof 22
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 2, 1999
Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assaysF Dati, M Panteghini, F S Apple, et al.
The Clinical Investigator|December 1, 1992
Endothelin-1 in patients with complicated and uncomplicated myocardial infarctionP Lechleitner, N Genser, J Mair, et al.
Clinical Chemistry|September 11, 1998
Different intracellular compartmentations of cardiac troponins and myosin heavy chains: a causal connection to their different early release after myocardial damageJ Bleier, K P Vorderwinkler, J Falkensammer, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 1, 1992
Effects of exercise on plasma myosin heavy chain fragments and MRI of skeletal muscleJ Mair, A Koller, E Artner-Dworzak, et al.
Clinical Chemistry|February 25, 1998
Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator usedN Genser, P Lechleitner, J Maier, et al.
Coronary Artery Disease|October 1, 1994
Concentration time courses of troponin and myosin subunits after acute myocardial infarctionJ Mair, B Thome-Kromer, I Wagner, et al.
Clinical Chemistry|June 1, 1993
Plasma immunoreactive endothelin in the acute and subacute phases of myocardial infarction in patients undergoing fibrinolysisP Lechleitner, N Genser, J Mair, et al.
Klinische Wochenschrift|November 9, 1990
Acute phase response after myocardial infarction: correlation between serum levels of cytokines and C-reactive proteinH Tilg, J Mair, M Herold, et al.
Clinical Chemistry|June 1, 1991
Cardiac troponin T in diagnosis of acute myocardial infarctionJ Mair, E Artner-Dworzak, P Lechleitner, et al.
Clinical Chemistry and Laboratory Medicine|September 4, 1999
Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. International Federation of Clinical ChemistryM Panteghini, F S Apple, R H Christenson, et al.
Pageof 22

Showing results (101-110 of 211) with videos related to

Sort By:
Pageof 22
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 2, 1999
Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assaysF Dati, M Panteghini, F S Apple, et al.
The Clinical Investigator|December 1, 1992
Endothelin-1 in patients with complicated and uncomplicated myocardial infarctionP Lechleitner, N Genser, J Mair, et al.
Clinical Chemistry|September 11, 1998
Different intracellular compartmentations of cardiac troponins and myosin heavy chains: a causal connection to their different early release after myocardial damageJ Bleier, K P Vorderwinkler, J Falkensammer, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 1, 1992
Effects of exercise on plasma myosin heavy chain fragments and MRI of skeletal muscleJ Mair, A Koller, E Artner-Dworzak, et al.
Clinical Chemistry|February 25, 1998
Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator usedN Genser, P Lechleitner, J Maier, et al.
Coronary Artery Disease|October 1, 1994
Concentration time courses of troponin and myosin subunits after acute myocardial infarctionJ Mair, B Thome-Kromer, I Wagner, et al.
Clinical Chemistry|June 1, 1993
Plasma immunoreactive endothelin in the acute and subacute phases of myocardial infarction in patients undergoing fibrinolysisP Lechleitner, N Genser, J Mair, et al.
Klinische Wochenschrift|November 9, 1990
Acute phase response after myocardial infarction: correlation between serum levels of cytokines and C-reactive proteinH Tilg, J Mair, M Herold, et al.
Clinical Chemistry|June 1, 1991
Cardiac troponin T in diagnosis of acute myocardial infarctionJ Mair, E Artner-Dworzak, P Lechleitner, et al.
Clinical Chemistry and Laboratory Medicine|September 4, 1999
Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. International Federation of Clinical ChemistryM Panteghini, F S Apple, R H Christenson, et al.
Pageof 22